Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
Clinical trial NCT03208465 · COMPLETED
Trial details
- NCT number
- NCT03208465
- Sponsor
- CHEOL WHAN LEE, M.D., Ph.D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2019-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.